Subcutaneous and Visceral Fat

The ZERONA™ device was developed following an exhaustive investigation analyzing low-level-laser therapy’s efficacy of emulsification of fat tissue.  It has been soundly concluded that laser therapy, at a specific wavelength and frequency proven by Erchonia®  Medical, induces the formation of a transitory pore in the bilipid membrane of adipocyte cells, permitting the fatty contents housed within these cells to trickle into interstitial space. 

Low-level-laser therapy is a non-invasive technology that overwhelmingly appeals to those individuals vigorously searching for a safe and highly effective fat reducing procedure. However, it is important to understand the limits of this new and innovative technology. An individual who is classified as being obese possesses an excess amount of body fat.  Fat droplets, generally composed of triglycerides, are stored in adipocytes, and as an individual accumulates more and more fats, the adipocytes enlarge.  Adipocytes are the predominate cell of adipose tissue.  In humans, there are two regions in which adipose tissue is located, subcutaneously and viscerally.  Subcutaneous fat resides directly beneath the skin while visceral fat is found in the peritoneal cavity around internal organs. 

Herein lies an important distinction; it is the subcutaneous fat not the visceral fat, that the ZERONA™ targets.  Visceral fat is situated inside the peritoneal cavity providing a protective cushion for our internal organs (figure 1).  

However, as an individual accumulates fats, the adipocyte cells comprising the visceral fat become enlarged resulting in an undesirable midsection.  This particular fat lies directly under the abdominal skeletal muscle and therefore making it extremely difficult to treat with laser light. 

As the ZERONA™ laser penetrates the skin, the light is immediately absorbed by a photoacceptor molecule situated in the mitochondria; it is this primary reaction that consequentially induces a chain of secondary reactions that eventually lead to the formation of the transitory pore.  The superficial nature of the subcutaneous fat layer allows it to be ideally targeted by the ZERONA™. 

The ZERONA™ provides a head start for those individuals wishing to change their life, but it is most important to fully understands the limitations of laser therapy; therefore, without a lifestyle change to help manage visceral fat, one may not see the results that one strongly desires or the ZERONA™ promises.

Erchonia®  ZERONA™ Biochemical Effects on Adipose Tissue

    

The stunning series of photographs above impressively demonstrates low-level-lasers ability to emulsify adipose tissue.  The pictures reveal the collapse of the rigid adipose cell and the secretion of triglycerides and fatty acids.  These remarkable imagines immediately reveal why laser-assisted liposuction can serve as a great benefit for the physician and the patient.

As you begin the aspiration phase of your procedure, imagine soft emulsified adipose tissue allowing you to apply significantly less force needed to break down the adipose tissue; resulting in no bruising, quicker recovery times, and no  inflammation or pain.

Why Do Triglycerides and Fatty Acids Seep Across the Membrane

The images directly above reveal the formation of a transitory pore forming in the bi-lipid membrane of an adipose cell.  This pore formation is the direct result of laser stimulation, and the reason why the triglycerides and fatty acids move into extracellular space.  The pore is not damaging to the cell, but simply serves as a means for the fatty contents of the cell to evacuate.  The formation of the transitory pore is the product of a series of secondary reactions originating in the mitochondria.